OBAGADAFFI:
TRANSCORP on full-offer

419 coy.

Expected. It was performing the Japaul hurdle so anyone still there is a gambler.

GTB: Bids higher than offer now......with a bulk of the bids at 33 and below......
Access: did 8.50 while UBA is maintaining 9, this equation no balance.......Access will go back to 9 or UBA will come down..
FCMB:. MM to the rescue.....
.

swilo:


Expected. It was performing the Japaul hurdle so anyone still there is a gambler.

Neimeth can't be going up and GSK looking down.I love Gsk response to trade today.
Tomorrow is another day.

swilo:


Expected. It was performing the Japaul hurdle so anyone still there is a gambler.

Transcorp is no more a gambling company.
I am expecting a corporate action that has to do with reconstruction soonest.

https://amp.theguardian.com/world/2020/nov/16/moderna-covid-vaccine-candidate-almost-95-effective-trials-show?__twitter_impression=true

Another covid vaccine is here.

emmanuelewumi:
2% of bank customers have 98% of the deposits.

Just 2% of bank customers have 500k and above in their accounts. Over 99% have 100k and below.

....... meaning, if the masses decides to boycott, na wahala for the bank shey!
Its well. Thanks for the correction and supporting doc sir.

The volatility these past few days has been interesting.

The bleeding should stop tomorrow.

PharmAlfred:
The volatility these past few days has been interesting.

The bleeding should stop tomorrow.

Abeg the bleeding should continue, let us re-enter some of these bloody banks.

Mcy56:
GTB: Bids higher than offer now......with a bulk of the bids at 33 and below......
Access: did 8.50 while UBA is maintaining 9, this equation no balance.......Access will go back to 9 or UBA will come down..
FCMB:. MM to the rescue.....
.

I am sure bear doesn't come with indecision.Indicision we see now is the effect of circuit breaker which occured last week.

I am sure when the bears come,10 10% fall is eminent.

More upside

INTBREW:
Got lots of cross deals today at N7........
Is there another renewed interest here from some entities or money bags?
We keep watching.......

Cc: My fellow Intbrew lovers......

Mcy56:

....... meaning, if the masses decides to boycott, na wahala for the bank shey!
Its well. Thanks for the correction and supporting doc sir.

The real customers won't come to the social media to boycott the services of Access Bank

onegentleguy:


Heard that Canada and 2 other European countries made a $1 billion and $2.1 billion respective upfront payments to GLAXOSMITKLINE(GSK), PFIZER and JOHNSON & JOHNSON(J&J) for the early provision of covid-19 vaccine to ensure early access on usage.
The 1st coy(GSK) has a subset quoted on the NSE, while the 2nd is affiliated to NEIMETH, another quoted coy on the exchange.

Beyond this though, GSK is grossly underpriced !!

Selah

The text in bold will benefit only GlaxoSmithKline's shares that are quoted on both the London and New York Stock Exchanges, not GSK Consumer Nigeria Plc.

locodemy:
I am sure bear doesn't come with indecision.Indicision we see now is the effect of circuit breaker which occured last week.

More upside

Judging from the volumes and closing, this price falls looks temporal.
GTB refused to fall to day's low of 24 something, so also Zenith, Access, UBA, dangcem and quite a lot of stocks ......
Bids even outweigh offers in GTB.......the market mirror ..

Reversal (up) may occur this week again from the look of things......
Let's see how it goes......

locodemy:


Transcorp is no more a gambling company.
I am expecting a corporate action that has to do with reconstruction soonest.

But after buying at 0.56 with AFS figures in the negatives and refusing to sell at 1.02… 1.10… 1.20… 1.30... with AFS figures still in the negatives, and all the people previously trapped waiting to get out, then that individual is a newbie like me.

locodemy:


I don't know o.
I am not a long term investor.
I don't bother to know because once my exit price is met,na to drop Kaya.

tnota:


The text in bold will benefit only GlaxoSmithKline's shares that are quoted on both the London and New York Stock Exchanges, not GSK Consumer Nigeria Plc.

Who will get the right for the manufacture or sales of the vaccine in Nigeria and West Africa?

swilo:


Be careful with Fidson and GSK.

I am now heavily loaded on GSK... It's worth the risk joor

OBAGADAFFI:
TRANSCORP on full-offer

419 coy.

I sold off last week... Left just few because I no trust TONY and his gang

swilo:


Check the charts and check the figures. I expect a whole month of indecision before the market begins to look down.

Except of course more hot monies come in.

We are watching bro... I'm already in be I am IN

emmanuelewumi:



Who will be get the right for the manufacture or sales of the vaccine in Nigeria and West Africa?

They might not manufacture vaccines in Nigeria.

Most companies will Import from their parent companies and partners abroad.

megawealth01:
I sold off last week... Left just few because I no trust TONY and his gang

emmanuelewumi:



Who will be get the right for the manufacture or sales of the vaccine in Nigeria and West Africa?

You dey mind am?

OBAGADAFFI:



They might not manufacture vaccines in Nigeria.

Most companies will Import from their parent companies and partners abroad.

The news alone will make that GSK go gaga... I bought to test the WATERS sha

megawealth01:
The news alone will make that GSK go gaga... I bought to test the WATERS sha

Yes.

NEIMETH should be talking to Pfizer now.

arduino:

I was forced to use their platform sha. Their platform is very basic compared to Morgan capital. Also their buy/sell commissions na die...

How expensive is their commission?

tnota:


The text in bold will benefit only GlaxoSmithKline's shares that are quoted on both the London and New York Stock Exchanges, not GSK Consumer Nigeria Plc.

There will be signing of MOU with FG through Gsk consumer Nigeria plc and the parent company is there to assist them 100%.

I am seriously waiting for an announcement of covid vaccine in Naija.

For now,The health sector is bullish and will remain bullish till January.

Secondly,the more Neimeth rises,Gsk and Fidson will be forced to rise sharply.

The TA is bullish.

samzepaparazi:


should we still be expecting january bull like this

In view of the recent market rally, many NSE participants and onlookers have been asking if current price levels are justified and if the bullish trend will continue.

Let's consider some salient factors:

A. POSITIVE SIDE - BULLISH EFFECT
1. Treasury Bill and OMO rates: Very low (below 2% p/a); part of the maturing funds will continue to enter the stock market.
2. FPI vs Locals ratio: Uncharacteristically, recent rally is majorly from locals.
3. PFA & corporates: Hunting for better returns, entering the stock market.
4. Local investors: Gradually building up interest in the stock market.
5. Fundamentals: Some companies' share prices are still clearly undervalued e.g. even at N40 per share, Zenith Bank would still have a projected dividend yield of 7% at year end.
6. Long term investors: Many of the local and corporate investors are buying majorly blue-chips, for the long term.
7. Extraneous factors: e.g. Covid-19 vaccine discovery is bullish for healthcare companies, imminent completion of Dangote petrochemicals refinery is bullish for oil and gas companies, etc.

B. NEGATIVE SIDE - BEARISH EFFECT
1. Delayed results, esp. FUGAZ: This makes short-termers nervous, and may precipitate profit-taking.
2. December effect: A lot of people raise money for Christmas/ new year expenses late Nov and early Dec.
3. Year End book-keeping: Some corporates sell down to prepare for 31st Dec closing of their books.
4. Speculators/ Hot money: Many of those entering the market are only hunting short term gains. They will quickly panic and sell at the slightest sign of price reversals.

Overall, I believe our market bull still has some steam left.

See attached data of 5 year Price Range vs Dividend Yields, for some companies....

OBAGADAFFI:



They might not manufacture vaccines in Nigeria.

Most companies will Import from their parent companies and partners abroad.

GSK Nigeria will benefit from whatever happens to the parent company. The parent company own about 60% of the Nigerian subsidiary

PETERiCHY:


Most stocks has done more than 100% upside from their March low and you are still waiting for more direction

Except Guinness, seplat and a handful of others

emmanuelewumi:



Who will be get the right for the manufacture or sales of the vaccine in Nigeria and West Africa?

A few days ago, VP Osibanjo said one of Nigeria's key priorities will be to get the vaccines. He didn't add more details how they will source for them. Whether they will pick Pfizer, GSK, Sanofi or others, we don't know. If they pick GSK, GSK Consumer Nigeria Plc will benefit.

However, it will be helpful to study several vaccine candidates and the level of their progress.

emmanuelewumi:



Who will get the right for the manufacture or sales of the vaccine in Nigeria and West Africa?

Do you also believe we will manufacture any covid-19 vaccine in Nigeria?